In her role, Garlikov will serve as a member of the point-of-need molecular diagnostic developer’s executive team and will be responsible for driving commercial strategy for the decentralized diagnostics platform.
Garlikov will report to Bryan Dechairo, who serves as president and CEO of the Watertown, Massachusetts-based company, according to a news release.
She joins Sherlock with more than 20 years of sales and marketing experience, having held roles at Grail, Rodan + Fields, PepsiCo, Johnson & Johnson and Procter & Gamble. At Grail, she was VP of marketing where she helped define the market for the first multi-cancer early detection blood screening test, Sherlock said.
Garlikov has played a role in positioning the company for its next stage of growth from an R&D organization to a commercia…